Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-24 @ 3:43 PM
NCT ID: NCT01871792
Eligibility Criteria: Inclusion Criteria: * Age ≥ 19 years * Need for coronary angiography or intervention in patients with typical symptoms for angina or myocardial infarction, or documented myocardial ischemia at non-invasive studies including ECG, treadmill ECG test, heart spect or coronary CT angiography * Estimated glomerular filtration rate ≤60 mL/min * Informed consent Exclusion Criteria: * Need for primary percutaneous coronary intervention or emergent intervention in patients with myocardial infarction * Allergic reaction for contrast agent (Visipaque) or statin * Contraindication for contrast agent (Visipaque) or statin * Shock status fron any cause including cardiogenic shock * Statin use before enrollment (Enrollment after 2 weeks of wash-out period) * Exposure of contrast agent within 7 days before enrollment * Pregnancy or Expectation for pregnancy in women of childbearing age * Heart failure (NYHA class ≥3 or left ventricular ejection fraction \< 40%) * Acute renal injury * Dialysis therapy * Mechanical ventilator * Life expectancy \< 6 months * Non-steroidal anti-inflammatory drug, dopamine, mannitol or N-acetylcysteine, ascorbic acid within 48 hours before and after coronary angiography/intervention * Severe hepatic dysfunction * Eisenmenger syndrome or idiopathic pulmonary hypertension * Renal artery angioplasty within 6 months * Single functioning kidney * Kidney transplantation
Healthy Volunteers: False
Sex: ALL
Minimum Age: 19 Years
Study: NCT01871792
Study Brief:
Protocol Section: NCT01871792